As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient. 🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories. 🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities. 💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders. Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry. " title="" class="btn" data-container="body" data-html="true" data-id="182023" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Paris Saclay Cancer Cluster (PSCC)"> 8,408
Activities
Entity types
Location
94800 Villejuif, France
Villejuif
France
Employees
Scale: 2-10
Estimated: 22
Engaged corporates
41Added in Motherbase
2 years agoBringing together the actors of oncology innovation to develop solutions in France for the patients.
As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.
🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.
🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.
💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.
Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
oncologie, Cancer, Innovation, and Oncocluster
Bringing together the actors of oncology innovation to develop solutions in France for the patients.
As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.
🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.
🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.
💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.
Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
Découvrez le Paris Saclay Cancer Cluster, un écosystème dédié à l’innovation en oncologie pour accélérer les découvertes. Accompagnement de startups biotech dans la recherche contre le cancer.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Future4Care Startup accelerator & VC | Future4Care Startup accelerator & VC | Other 18 Feb 2025 | | |
![]() Maison du doctorat - Université Paris-Saclay Research, Higher Education | Maison du doctorat - Université Paris-Saclay Research, Higher Education | Other 30 Jan 2025 | | |
![]() Grand Paris Express National and local authorities, Truck Transportation | Grand Paris Express National and local authorities, Truck Transportation | Other 12 Jan 2025 | | |
![]() Kamet Ventures Venture Capital and Private Equity Principals | Kamet Ventures Venture Capital and Private Equity Principals | Other 30 Nov 2024 | | |
![]() La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | Other 9 Jan 2025 | | |
![]() Astellas Pharma Pharmaceutical | Astellas Pharma Pharmaceutical | Other 2 Oct 2024 | | |
![]() Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 1 Oct 2024 | | |
![]() Technofounders Research, Research Services | Technofounders Research, Research Services | Other 1 Oct 2024 | | |
![]() Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 1 Oct 2024 | | |
![]() Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 1 Oct 2024 | |